
Turn Therapeutics Inc
TTRXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$5.31
Day High
$5.46
Day Low
$4.57
Prev. Close
$5.31
VolumeShares traded today.
145.11K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$154.90M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-38.60
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$26.50
52W LowLowest price over the past 52 weeks.
$2.57
50D MAAverage closing price over the last 50 trading days.
$3.81
200D MAAverage closing price over the last 200 trading days.
—
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+4.6%1M
+46.3%6M
+57.6%YTD
+10.9%1Y
-25.7%About
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
turntherapeutics.comCompany Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade TTRX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.